Evolving Strategies of Care in Pulmonary Arterial Hypertension

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hours of continuing education (which includes 0.75 hours of pharmacology)

Description:?
Pulmonary arterial hypertension (PAH) is a subgroup of pulmonary hypertension (PH) and a chronic, progressive condition characterized by abnormally high pressure in the pulmonary vasculature. PAH has previously been considered a rare disease, but evidence suggests a prevalence of about 15-50 cases per million. In the United States, about 1,000 new cases of PAH are diagnosed each year.

The prognosis of PAH has improved with the availability of newer therapies, but outcomes are dependent on early diagnosis and treatment. This activity utilizes segments of a presentation by the faculty recorded at the Emerging Challenges in Primary Care Live Virtual Symposium: 2018, to reinforce teaching points made during this program. This program will address recognizing the signs and symptoms of PAH, performing an appropriate diagnostic evaluation, current treatment paradigm, managing adverse medication events and when to refer to tertiary PH centers